Global Type 1 Diabetes Market Projected to Reach USD 2,800 Million by 2026

19-Jun-2020 | Facts and Factors

Findings from Facts and Factors report “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global type 1 diabetes market in 2019 was approximately USD 2,000 million. The market is expected to grow above a CAGR of 5.0% and is anticipated to reach over USD 2,800 million by 2026.

Type 1 Diabetes Market Size

Request Sample Request Customization Buy Now

Type 1 diabetes is type of diabetes where an autoimmune response towards insulin-making beta cells of the pancreas leads to the early destruction of the pancreas. Type 1 diabetes mellitus is idiopathic but has a strong association with genes such as HLA-DR4 and HLA-DR3. Type 1 diabetes symptoms are increase thrust, extreme weight loss stomach upset, increase the frequency of urination, fatigue, delayed healing, etc. One of the key remedies against type 1 diabetes in insulin therapy. Parents and the child should have proper knowledge of the condition. The primary goal in the case of type 1 diabetes is to keep the insulin level as close to normal. The treatment prescribed to the patient involves monitoring the blood sugar level within limit via diet, exercise, and insulin therapy. If left untreated, the type 1 diabetic patient experiences loss of consciousness. Uncontrolled diet and insulin may cause high blood sugar (hyperglycemia), increased ketones in urine, hypoglycemia, etc.

Browse the full “Type 1 Diabetes Market By Insulin Analog (Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs, and Premix Insulin Analogs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/type-1-diabetes-market-by-insulin-analog-rapid-1256

In the last few years, there has been a steady rise in type one diabetes in children. Changing lifestyle in urban and rural parts of the world have led to the high exposure of pollution and unhealthy diet patterns among children, which has led to an increase in the number of children affected with type 1 diabetes. Type 1 diabetic patients have to rely solely on external insulin supply. These patients have to carry insulin pens for medication. Owing to such primary dependency of patients insulin has driven the global injectable insulin market. With the advancements of biomedical technology, the emergence of genetic consulting is anticipated to create new types of treatments for type 1 diabetes. Also, the Food and Drug Administration approved the first-ever artificial pancreas for type 1 diabetic patients aging 14 and old. Such technological advancements are likely to create new avenues for the global type 1 diabetic market. However, lack of awareness among patients regarding types of treatment available has hampered the market for injectable insulin for type 1 diabetes.

Based on insulin analog, the rapid-acting insulin analogs segment dominated the global type 1 diabetes market, accounting for a market share of 40% in 2019. A rapid-acting insulin is taken 15 minutes before a meal. Rapid-acting insulin has an onset and peak of nearly 15 minutes and 30 to 90 minutes respectively. Rapid-acting insulin offers a key advantage as it controls postprandial glucose.

Based on geography, the North America segment dominated the global type 1 diabetes market in 2019.  The North America region held a major share of nearly 35% in the global type 1 diabetes market in 2019. The growth in the region is attributable to rising consumer spending on healthcare and advancements in healthcare technology. Further, the increase in the number of type 1 diabetic patients has also contributed to driving the North America type 1 diabetes market.

Report Scope

Report Attribute

Details

Market Size in 2019

USD 2,000 Million

Projected Market Size in 2026

USD 2,800 Million

CAGR Growth Rate

5.0% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

B.BraunMelsungen AG, AstraZeneca PLC., Bayer Pharmaceuticals, DiaVacs Inc., Eli Lilly and Company, Novo Nordisk, Sanofi, Takeda Pharmaceutical, XOMA Corp., Biodel Inc., Macrogenics Inc., and Others

Key Segment

By Insulin, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

Some of the leading players in the global market include

B.BraunMelsungen AG, AstraZeneca PLC., Bayer Pharmaceuticals, DiaVacs Inc., Eli Lilly and Company, Novo Nordisk, Sanofi, Takeda Pharmaceutical, XOMA Corp., Biodel Inc., Macrogenics Inc., and Others.

This report segments the type 1 diabetes market as follows:

By Insulin Analog Segmentation Analysis

  • Rapid-Acting Insulin Analogs
  • Long-Acting Insulin Analogs
  • Premix Insulin Analogs

By Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com

 


Latest Market Research Reports

report img

Cloud Based Collaboration Software Market Report 2024 – 2032

[226+ Pages Report] According to Facts and Factors,the global cloud-based collaboration software market size was valued at USD 10.75 billion in 2023 and is predicted to surpass USD 33.60 billion by the end of 2032. The cloud-based collaboration software industry is expected to grow by a CAGR of 13.

Published Date : 26-Feb-2024 | | Category : Technology & Media | Pages : 226 | Format : Read more

Inquiry for Buying Request Sample
report img

Industrial Plant Derived Cleaning Ingredients Market Report 2024 – 2032

[221+ Pages Report] According to Facts and Factors,the global industrial plant derived cleaning ingredients market size was valued at USD 5,126.35 million in 2023 and is predicted to surpass USD 9,795.57 million by the end of 2032. The industrial plant derived cleaning ingredients industry is expec

Published Date : 21-Feb-2024 | | Category : Chemical & Materials | Pages : 221 | Format : Read more

Inquiry for Buying Request Sample
report img

Ophthalmic Laser Market Report 2024 – 2032

[220+ Pages Report] According to Facts and Factors,the global ophthalmic laser market size was valued at USD 1,358.79 million in 2023 and is predicted to surpass USD 2,126.07 million by the end of 2032. The ophthalmic laser industry is expected to grow by a CAGR of 5.76% between 2024 to 2032. Ophth

Published Date : 20-Feb-2024 | | Category : Medical Device | Pages : 220 | Format : Read more

Inquiry for Buying Request Sample
report img

Intraoperative Imaging Market Report 2024 – 2032

[219+ Pages Report] According to Facts and Factors,the global intraoperative imaging market size was valued at USD 3,471.52 million in 2023 and is predicted to surpass USD 6,286.27 million by the end of 2032. The intraoperative imaging industry is expected to grow by a CAGR of 7.70% between 2024 to

Published Date : 19-Feb-2024 | | Category : Healthcare | Pages : 219 | Format : Read more

Inquiry for Buying Request Sample
report img

Plant-based Food Colors Market Report 2024 – 2032

[216+ Pages Report] According to Facts and Factors,the global plant-based food colors market size was valued at USD 9.65 billion in 2023 and is predicted to surpass USD 15.31 billion by the end of 2032. The plant-based food coloring industry is expected to grow by a CAGR of 5.94% between 2024 to 20

Published Date : 16-Feb-2024 | | Category : Food & Beverages | Pages : 216 | Format : Read more

Inquiry for Buying Request Sample

Why FnF Market Research?

1 Inflallible Methodology

to ensure high-level data integrity, accurate analysis, and impeccable forecasts

2 Analyst Support

for complete satisfaction

3 Customization

on-demand customization of scope of the report to exactly meet your needs

4 Targeted Market View

Targeted market view to provide pertinent information and save time of readers

5 Agile Approach

A faster and efficient way to cater to the needs with continuous iteration